the us chinese anti - cancer association ( uscaca ,  , http://www.uscaca.org/ ) is a non - profit professional organization founded in 2009 . with members from academia , industry and government
, uscaca facilitates collaboration among cancer research and physicians in the united states and china .
our current focus is on expediting novel cancer drug development by fostering clinical trial networks , sharing best practices and knowledge of clinical trials , and providing education and training opportunities .
uscaca collaborates with chinese anti - cancer association ( caca ,  ) , chinese society for clinical oncology ( csco ) , and other pro - fessional associations .
the uscaca - csco joint session organizing committee co - chairs : jian ding , helen chen , li yan uscaca : roger luo , pascal qian
 the us chinese anti - cancer association ( uscaca ) teamed up with chinese society of clinical oncology ( csco ) to host a joint session at the17th csco annual meeting on september 20th , 2014 in xiamen , china . with a focus on breakthrough cancer medicines , 
 the session featured innovative approaches to evaluate breakthrough agents and established a platform to interactively share successful experiences from case studies of 6 novel agents from both the united states and china . 
 the goal of the session is to inspire scientific and practical considerations for clinical trial design and strategy to expedite cancer drug development in china . a panel discussion further provided in - depth advice on advancing both early and full development of novel cancer medicines in china . 